Orfanoudaki Maria, Wang Dongdong, Du Lin, Ruchirawat Somsak, Kittakoop Prasat, Grkovic Tanja, Mahidol Chulabhorn, O'Keefe Barry R
Molecular Targets Program, Center for Cancer Research, National Cancer Institute, Frederick, MD, 21702-1201, United States.
Chulabhorn Research Institute, Kamphang Phet 6 Road, Bangkok, 10210, Thailand; Chulabhorn Graduate Institute, Kamphang Phet 6 Road, Bangkok, 10210, Thailand; Center of Excellence on Environmental Health and Technology, CHE Ministry of Education, Bangkok, Thailand.
J Ethnopharmacol. 2025 Jun 25;352:120167. doi: 10.1016/j.jep.2025.120167.
Erythrophleum teysmannii (Kurz) Craib is a medicinal plant used by traditional healers in Laos and Thailand to treat cancer. Despite ethnopharmacological reports about plant extracts from this genus as cancer drug formulae, there is a knowledge gap about the chemical composition and potential pharmacological effects of E. teysmannii.
The study aimed to investigate the phytochemical constituents of the leaf and twig DCM/MeOH extract of E. teysmannii and their antiproliferative properties, and to support its traditional uses.
Bioassay-guided phytochemical investigation of the organic solvent extract of the plant led to the isolation of 21 pure compounds. Their structures were determined by extensive spectroscopic and spectrometric analyses, chemical derivatization and hydrolysis approaches, and ECD computational studies. Pure compounds were assessed for their antiproliferative activities against a panel of NCI-60 human tumor cell lines.
Thirteen new cassaine diterpenoid amine monomers erythroteysamines A-M (1, 4-9, 11-14, 16, and 19) and two new dimers erythroteysamines N and O (20 and 21), together with six previously reported analogues (2, 3, 10, 15, 17, and 18) were isolated. Sixteen compounds were tested in the NCI-60 assay, and they all averaged low micromolar antiproliferative potency.
The isolated compounds from E. teysmannii showed antiproliferative activities, providing chemical and pharmacological evidence supporting the traditional use of the plant in herbal medicine.
泰氏非洲箭毒木(Erythrophleum teysmannii (Kurz) Craib)是一种药用植物,老挝和泰国的传统治疗师用其治疗癌症。尽管有关于该属植物提取物作为癌症药物配方的民族药理学报道,但对于泰氏非洲箭毒木的化学成分和潜在药理作用仍存在知识空白。
本研究旨在调查泰氏非洲箭毒木叶和嫩枝的二氯甲烷/甲醇提取物的植物化学成分及其抗增殖特性,以支持其传统用途。
对该植物的有机溶剂提取物进行生物测定导向的植物化学研究,分离出21种纯化合物。通过广泛的光谱和光谱分析、化学衍生化和水解方法以及电子圆二色性(ECD)计算研究确定了它们的结构。评估了纯化合物对一组NCI-60人肿瘤细胞系的抗增殖活性。
分离出13种新的卡西烷二萜胺单体,即泰氏非洲箭毒胺A - M(1、4 - 9、11 - 14、16和19)以及2种新的二聚体,泰氏非洲箭毒胺N和O(20和21),还有6种先前报道的类似物(2、3、10、15、17和18)。16种化合物在NCI - 60测定中进行了测试,它们的抗增殖效力平均为低微摩尔浓度。
从泰氏非洲箭毒木中分离出的化合物显示出抗增殖活性,为该植物在草药医学中的传统用途提供了化学和药理学证据。